Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma

Journal of the American Animal Hospital Association

Volumn 43, Issue 2, 2007, Pages 85-92

  Kaiser, Claire Inderbinen ^a   Fidel, Janean L ^b   Roos, Malgorzata ^a   Kaser Hotz, Barbara ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 34249802602     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0430085     Document Type: Article

References (20)

1. Vail DM, MacEwen EG, Young KM. Canine lymphoma and lymphoid leukemias. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. 3rd ed. Philadelphia: WB Saunders, 2001: 558-590.
2. Teske E, van Heerde P, Rutteman GR, et al. Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 1994;205:1722-1728.
3. Rassnick KM, Mauldin GE, Al-Sarraf R, et al. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000). J Vet Intern Med 2002;16:576-580.
4. Rosenthal RC, MacEwen EG. Treatment of lymphoma in dogs. J Am Vet Med Assoc 1990;196:774-780.
5. Jagielski D, Lechowski R, Hoffmann-Jagielska M, et al. A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000). J Vet Med A Physiol Pathol Clin Med 2002;49:419-424.
6. Kiupel M, Teske E, Bostock D. Prognostic factors for treated canine malignant lymphoma. Vet Pathol 1999;36:292-300.
7. Starrak GS, Berry CR, Page RL, et al. Correlation between thoracic radiographic changes and remission/survival duration in 270 dogs with lymphosarcoma. Vet Radiol Ultrasound 1997;38:411-418.
8. Greenlee PG, Filippa DA, Quimby FW, et al. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990;66: 480-490.
9. Baskin CR, Couto CG, Wittum TE. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study. J Am Anim Hosp Assoc 2000;36:404-409.
10. Dobson JM, Blackwood LB, McInnes EF, et al. Prognostic variables in canine multicentric lymphosarcoma. J Small Anim Pract 2001;42:377-384.
11. Rosenberg W, Matus RE, Patnaik AK. Prognostic factors in dogs with lymphoma and associated hypercalcemia. J Vet Intern Med 1991;5:268-271.
12. Keller ET, MacEwen EG, Rosenthal RC, et al. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 1993;7:289-295.
13. Vail DM, Kisseberth WC, Obradovich JE, et al. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Exp Hematol 1996;24:807-815.
14. Garrett LD, Thamm DH, Chun R, et al. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002;16:704-709.
15. Northrup NC, Rassnick KM, Snyder LA, et al. Neutropenia associated with vincristine and l-asparaginase induction chemotherapy for canine lymphoma. J Vet Intern Med 2002;16:570-575.
16. Altman DG. Analysis of survival times. In: Practical Statistics for Medical Research. London: Chapman & Hall/CRC, 1994:365-395.
17. Altman DG. Comparing groups - categorical data. In: Practical Statistics for Medical Research. London: Chapman & Hall/CRC, 1994:229-276.
18. Boyce KL, Kitchell BE. Treatment of canine lymphoma with COPLA/LVP. J Am Anim Hosp Assoc 2000;36:395-403.
19. Chun R, Garrett LD, Vail DM. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2000;14:120-124.
20. Ponce F, Magnol JP, Ledieu D, et al. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet J 2004;167:158-166.